Novomore Biotechnology
Changsha
About Novomore Biotechnology
Hunan Nuohexin Biotechnology is a provider and developer of plant-derived recombinant protein expression products with technology research and product development, integrating production, research and development, sales, and services that can produce monoclonal antibodies, cell growth factors, vaccines, and plant-derived diagnostic antibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $1.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: novomorebio.com
- Phone: +86 400-168-5038
Industries & Categories
Biopharma, Biotechnology, Product Research
Canonical: https://fsome.com/organization/novomore-biotechnology-185727 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.